The largest database of trusted experimental protocols

Respiratory virus oligo panel

Manufactured by Illumina
Sourced in United States

The Respiratory Virus Oligo Panel is a lab equipment product designed to detect and identify a wide range of respiratory viruses. It utilizes a targeted gene sequencing approach to provide comprehensive viral detection capabilities.

Automatically generated - may contain errors

5 protocols using respiratory virus oligo panel

1

Respiratory Virus Sequencing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sequencing for a first set of samples was performed at the Microbial Genome Sequencing Center (Pittsburgh, PA) in three independent sequencing runs. A Maxima double-stranded cDNA RT kit (Thermo Fisher) was used to generate cDNA. An Illumina Flex for Enrichment kit paired with an Illumina Respiratory Virus Oligo Panel (Illumina, Inc.) was used to enrich for respiratory virus cDNA with 15 PCR cycles in the final step. The libraries were then sequenced on a NextSeq 550 to yield on average 119 Mbp of 2 × 75 bp paired-end sequencing reads. For a second set of samples (see Table S1), rRNA depletion was performed, and oligonucleotide capture enriched and unenriched sequencing strategies were compared. The rRNA depletion was done using RiboZero Plus supplemented with a comprehensive “Gut Microbiome” probe set. Libraries were prepared using the Illumina RNA Prep with Enrichment (L) Tagmentation protocol. The rRNA-depleted samples were amplified for 20 cycles. Enrichment was performed using the Illumina Respiratory Virus Oligo Panel.
+ Open protocol
+ Expand
2

SARS-CoV-2 Variant Analysis Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified RNA was prepared for sequencing using the Illumina RNA Prep with Enrichment (Illumina, 20040536) workflow, following the instructions for the Respiratory Virus Oligo Panel (Illumina, 20044311). The resulting libraries were run on a MiSeq instrument, with at least 1.5 million reads per sample. Reads were aligned to the SARS-CoV-2 MA10 genome using STAR (v2.7.9). Output BAM files were input into Geneious Prime, and variant calling was performed with a minimum of 100 reads per base and a quality score of 25, and a cutoff of 0.02 frequency variance. Variants in the nsp12 gene were averaged, then graphed along the length of the gene using a custom R script.
+ Open protocol
+ Expand
3

SARS-CoV-2 Genomic Surveillance via Automated Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Automated nucleic acid extraction was performed as described previously (20 (link), 21 (link)) using the chemagic 360 (PerkinElmer) following the manufacturer’s protocol. Whole genome sequencing and analysis were performed as previously described (23 (link)).
For a subset of samples, 25 ng of RNA, previously extracted using QIAGEN’s Viral RNA mini kit, was processed following the Illumina RNA Prep with Enrichment (L) Tagmentation protocol with Illumina Respiratory Virus Oligo Panel for single-plex enrichment. Libraries were sequenced on the Illumina MiSeq (2 × 76 bp) or iSeq (2 × 151 bp) platform. FASTQ files were analyzed in Illumina’s BaseSpace using the DRAGEN Pathogen Detection application to generate consensus files. The pangolin web-based application, Phylogenetic Assignment of named Global Outbreak LINeages (PANGOLIN) (https://pangolin.cog-uk.io/) was used to identify the SARS-CoV2 lineages from these consensus sequences. Nextclade (https://clades.nextstrain.org/) was used for clade assignment, sequence quality check, and phylogenetic tree construction.
+ Open protocol
+ Expand
4

SARS-CoV-2 Sequencing from Clinical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
A set of 126 isolates (Ct range 11.29–26.39; see Table S1) and one positive (pc-Illumina) and one negative (nc-Illumina) control were transcribed into ds cDNA using NEBNext® RNA First Strand Synthesis module and NEBNext UltraII Directional RNA Second Strand Synthesis module (New England Biolabs; Ipswich, MA, USA) following the manufacturer’s protocol.
Libraries were prepared using Nextera Flex for Enrichment (pre-enrichment part of manufacturer’s protocol; https://emea.support.illumina.com/sequencing/sequencing_kits/illumina-dna-prep-with-enrichment/documentation.html (accessed on 30 July 2021)). Next, libraries were combined in twelve plexes by 7–11 samples (including controls) based on the Ct values (in order to minimise the Ct difference in samples within each plex) and enriched using the Respiratory Virus Oligo Panel (Illumina, San Diego, CA, USA), following the manufacturer’s protocol (https://www.illumina.com/content/dam/illumina-marketing/documents/products/appnotes/coronavirus-enrichment-product-list-1270-2020-004.pdf accessed on 30 July 2021).
Enriched plexes were equally pooled based on evaluation by Qubit 2.0 and Bioanalyzer 2100 and sequenced on the MiSeq platform in a run with configuration 2 × 176 bp using MiSeq Reagent Kit v3 (600 cycle) (Illumina, San Diego, CA, USA).
+ Open protocol
+ Expand
5

Respiratory Virus Enrichment Sequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
A set of 35 isolates (Ct values 11.29–40, Supplementary Table S1)—4 positive (pc1, pc2, pc3, pc4) and 1 negative (nc2) controls—was transcribed into ds cDNA using NEBNext® RNA First Strand Synthesis Module and NEBNext® Ultra™ II Directional RNA Second Strand Synthesis Module (New England Biolabs; Ipswich, MA, USA) following manufacturer’s protocol.
Libraries were prepared using Nextera Flex for Enrichment (pre-enrichment part of manufacturer’s guide; https://emea.support.illumina.com/content/dam/illumina-support/documents/documentation/chemistry_documentation/illumina_prep/illumina-dna-prep-with-enrichment-reference-1000000048041-05.pdf). Next, libraries were combined within 8 plexes by 5 samples each based on Ct values (see Supplementary Table S1) and enriched using the Respiratory Virus Oligo Panel (Illumina, San Diego, CA, USA, following the manufacturer’s protocol (https://www.illumina.com/content/dam/illumina-marketing/documents/products/appnotes/coronavirus-enrichment-product-list-1270-2020-004.pdf).
Enriched plexes were equally pooled based on evaluation by Qubit 2.0 and Bioanalyzer 2100 and sequenced on the MiSeq platform using MiSeq Reagent Kit v3 (600 cycle) (Illumina, San Diego, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!